Table 1

Summary of study characteristics of included studies

First author, publication year, reference numberStudy designTiming of specimen collectionSpecimen typeTotal enrolled, NSample size for outcome,
events in women with Mycoplasma genitalium/total with the outcome, n/n (%)
PTBPROMLBWSABPND
Agger, 201421 Cohort1st or 2nd trimesterEndocervical swab783676,
0/54 (0)
NRNRNRNR
Averbach, 201319 Cohort*1st or 2nd trimesterEndocervical swab10066,
1/11 (9)
NR81,
1/11 (9)
81,
1/9 (11)
NR
Choi, 201222 Case–controlNRVaginal swab217217,
0/100 (0)
NRNRNRNR
Edwards, 200623 CohortNRNot clear137134†NRNRNRNR
Hitti, 20103 Case–control*<48 hours post partumEndocervical swab13381328,
29/661 (4)
NRNRNRNR
Kataoka, 200624 Cohort1st trimesterVaginal swab1040871,
0/15 (0)
871,
0/7 (0)
NR877,
0/5 (0)
872,
0/1 (0)
Labbe, 200220 Case–control<24 hours post partumEndocervical swab1014799,
16/119 (13)
NRNR653,
2/53 (4)
725,
8/125 (6)
Oakeshott, 200425 Cohort1st trimesterUrine1216699,
0/39 (0)
NRNR894,
1/92 (1)
NR
Rahimkhani, 201827 Cohort1st or 2nd trimesterUrine119NRNRNR119,
6/31 (19)
NR
Short, 201026 Case–control*NRUrine216NRNRNR213,
3/82 (4)
NR
  • *Authors reported both univariable and multivariable analyses.

  • †Numerator and denominator not reported in text. OR and 95% CI, as reported by authors, used in meta-analysis.

  • LBW, low birth weight; NR, not reported; PROM, premature rupture of membranes; PND, perinatal death; PTB, preterm birth; SAB, spontaneous abortion.